Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in AIDS

Retrieve available abstracts of 26 articles:
HTML format

Single Articles

    July 2021
  1. RUDDY JA, Boyarsky BJ, Bailey JR, Karaba AH, et al
    Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV.
    AIDS. 2021 Jul 8. pii: 00002030-900000000-96349.
    PubMed     Abstract available

    June 2021
  2. NDUATI EW, Gorman MJ, Sein Y, Hermanus T, et al
    Coordinated Fc-effector and neutralization functions in HIV-infected children define a window of opportunity for HIV vaccination.
    AIDS. 2021 Jun 10. pii: 00002030-900000000-96374.
    PubMed     Abstract available

    May 2021
  3. RUDDY JA, Boyarsky BJ, Werbel WA, Bailey JR, et al
    Safety and antibody response to the first dose of SARS-CoV-2 messenger RNA vaccine in persons with HIV.
    AIDS. 2021 May 14. pii: 00002030-900000000-96405.
    PubMed     Abstract available

  4. GOSENS KCM, van der Zee RP, van Heukelom MLS, Jongen VW, et al
    HPV vaccination to prevent recurrence of Anal Intraepithelial Neoplasia in HIV+ MSM: a randomised, placebo-controlled multicentre trial.
    AIDS. 2021 May 5. pii: 00002030-900000000-96413.
    PubMed     Abstract available

    April 2021
  5. PREININGER L, Kahal DA, Szabo S
    Hepatitis B vaccination response and safety in people living with HIV/AIDS receiving HepB-CpG series.
    AIDS. 2021;35:845-846.

    October 2019
  6. MEZA G, Exposito A, Royo JL, Ruiz-Garcia C, et al
    Association of CR2 genotypes with the acquisition of HIV infection in a trial of recombinant glycoprotein 120 Vaccine.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002401.
    PubMed     Abstract available

  7. BARRY PA, Deere JD, Yue Y, Chang WW, et al
    Cytomegalovirus (CMV)-Vectored vaccines for HIV and other pathogens.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002396.

  8. Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix): Erratum Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection: E
    AIDS. 2019;33:1957.

    August 2019
  9. FLYNN PM, Abrams EJ
    Response to correspondence entitled: Perinatal HIV and response to vaccination.
    AIDS. 2019;33:1675-1677.

  10. DAUBY N
    Perinatal HIV and response to vaccination.
    AIDS. 2019;33:1674-1675.

  11. FRENCH M
    Antibody-mediated control of HIV-1 infection through an alternative pathway.
    AIDS. 2019 Aug 1. doi: 10.1097/QAD.0000000000002313.
    PubMed     Abstract available

    July 2019
  12. DELL'ACQUA R, Galli L, Poli A, Mastrangelo A, et al
    Viro-immunological outcomes after thirteen-valent pneumococcal vaccination in HIV-1 infected subjects on stable virological suppression.
    AIDS. 2019 Jul 10. doi: 10.1097/QAD.0000000000002307.
    PubMed     Abstract available

  13. DURIER C, Desaint C, Lelievre JD, Silbermann B, et al
    Long-term safety and vaccine-induced seropositivity in healthy volunteers from HIV vaccine trials: a French cohort study.
    AIDS. 2019 Jul 10. doi: 10.1097/QAD.0000000000002310.
    PubMed     Abstract available

    March 2019

  14. Impact of aging and HIV infection on serologic response to seasonal influenza vaccination: Erratum.
    AIDS. 2019;33:771.

  15. MACHIELS JD, Braam EE, van Bentum P, van Vugt M, et al
    Vaccination with Fendrix of prior nonresponding patients with HIV has a high success rate.
    AIDS. 2019;33:503-507.
    PubMed     Abstract available

  16. PANNUS P, Adams P, Willems E, Heyndrickx L, et al
    In-vitro viral suppressive capacity correlates with immune checkpoint marker expression on peripheral CD8+ T cells in treated HIV-positive patients.
    AIDS. 2019;33:387-398.
    PubMed     Abstract available

    October 2018
  17. PALICH R, Ghosn J, Chaillon A, Boilet V, et al
    Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial.
    AIDS. 2018 Oct 15. doi: 10.1097/QAD.0000000000002058.
    PubMed     Abstract available

  18. LEAL L, Guardo AC, Moron-Lopez S, Salgado M, et al
    Phase I clinical trial of an intranodally administered mRNA based therapeutic vaccine against HIV-1 infection.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002026.
    PubMed     Abstract available

    September 2018
  19. LUO Z, Ogunrinde E, Li M, Zhang L, et al
    Increased influenza-specific antibody avidity in HIV-infected females compared to HIV-infected males on antiretroviral therapy.
    AIDS. 2018 Sep 17. doi: 10.1097/QAD.0000000000002022.
    PubMed     Abstract available

    August 2018
  20. COLIN DE VERDIERE N, Durier C, Samri A, Meiffredy V, et al
    Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients: ANRS EP46 NOVAA.
    AIDS. 2018 Aug 8. doi: 10.1097/QAD.0000000000001963.
    PubMed     Abstract available

    May 2018
  21. WINCKELMANN A, Morcilla V, Shao W, Schleimann MH, et al
    Genetic characterization of the HIV-1 reservoir after Vacc-4x and romidepsin therapy in HIV-1 infected individuals.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001861.
    PubMed     Abstract available

    April 2018
  22. GEORGE VK, Pallikkuth S, Pahwa R, de Armas L, et al
    Circulating inflammatory monocytes contribute to impaired influenza vaccine responses in HIV-infected participants.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001821.
    PubMed     Abstract available

    March 2018
  23. ISMAIL MF, Wong DK, Bogoch II
    The role for hepatitis A vaccination in HIV pre-exposure prophylaxis.
    AIDS. 2018;32:675-676.

    February 2018
  24. FARFOUR E, Lesprit P, Wai ACH, Mazaux L, et al
    Acute hepatitis A breakthrough in MSM in Paris area: implementation of targeted hepatitis A virus vaccine in a context of vaccine shortage.
    AIDS. 2018;32:531-532.

  25. PALLIKKUTH S, De Armas LR, Pahwa R, Rinaldi S, et al
    Impact of aging and HIV infection on serologic response to seasonal influenza vaccination.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001774.
    PubMed     Abstract available

  26. WEINBERG A, Huang S, Moscicki AB, Saah A, et al
    Persistence of memory B-cell and T-cell responses to the quadrivalent HPV vaccine in HIV-infected children.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001773.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.